GENEVA, July 9 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14 Jeyakgongdan 4-gil, Hyangnam-eup,Hwaseong-si,Gyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2024/019076) for "PREPARATION COMPRISING SEVELAMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PREPARING SAME" on Nov 28, 2024. With publication no. WO/2025/143585, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellect...